CD63 and colorectal cancer: Wang et al. designed an amplified aptasensor using graphene oxide and fluorescent labeled aptamers for CD63 and EpCAM on colorectal cancer exosome with a detection limit of 2.1 × 104 particles/μL and can be applied for clinical colorectal cancer serum samples in 5 μL [51].